Silverarc Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Silverarc Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$1.27M	Buy
2021 Q3	–	Sell
2021 Q2	$1.32K	Buy